Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Commentary
Nature Neuroscience 5, 1027–1029 (1 November 2002) | doi:10.1038/nn931
From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials
&
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
